References
- Alfirevic Z, Sundberg K, Brigham S. Amniocentesis and chorionic villus sampling for prenatal diagnosis. Cochrane Database Syst Rev 2003; 3: CD003252
- Sherman SL, Allen EG, Bean LH, Freeman SB. Epidemiology of Down syndrome. Ment Retard Dev Disabil Res Rev 2007; 13: 221–7
- Sundhedsstyrelsen: Retningslinjer for fosterdiagnostik – prænatal information, risikovurdering, rådgivning og diagnostik [The Danish National Board of Health: Guidelines for prenatal diagnosis. Information, risk assessment, counselling, and diagnosis] (in Danish. No abstract available)., Copenhagen: The National Board of Health, 2004.
- Spencer K, Spencer CE, Power M, Dawson C, Nicolaides KH. Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years prospective experience. BJOG 2003; 110: 281–6
- Sundhedstyrelsen: Fosterdiagnostik og risikovurdering – rapport fra en arbejdsgruppe [The Danish National Board of Health: Prenatal diagnosis and risk assessment – report from a working commission] (in Danish. No abstract available). Copenhagen: The National Board of Health, 2003.
- Cuckle H. Time for total shift to first-trimester screening for Down's syndrome. Lancet 2001; 358: 1658–9
- Larsen SO, Hansen J, Christiansen M, Nørgaard-Pedersen B. Prænatal diagnostik af Downs syndrom i Danmark 1980–1998 og perspektiver for den fremtidige udvikling. Ugeskr Laeger 2002; 164: 4532–6
- WHO/PAHO Consultation on CVS. Evaluation of chorionic villus sampling safety. Prenat Diagn. 1999;19:97–9.